Mr. Wensheng Fan is an executive, entrepreneur, and innovator with over 20 years of leadership experience in bringing ambitious, high-tech product ideas to life, including natural speech recognition, real-time imaging systems for self-driving cars, and FDA Breakthrough designated medical devices leveraging AI technologies. 

As a Co-Founder and the first employee of Spectral MD, Mr. Fan built and led the company for past 10 years. He has led Spectral MD to acquire over $250M in US federal government contracts from HHS/BARDA, NSF, NIH, DoD/DHA, and DoD/MTEC to fund the development and commercialization of DeepView®. He has also raised $39M in commercial funding to support large-scale clinical applications in the DFU and chronic wound markets. In 2021, Mr. Fan took Spectral MD to IPO on the London Stock Exchange (LSE: SMD) with an oversubscribed round. In 2023, Mr. Fan led the transition to a NASDAQ Global Market listing (Spectral AI, NASDAQ: MDAI).

With the success of Spectral MD, Mr. Fan joined Deep Rx to lead the efforts to bring the state-of-the-art AI to cancer care.